Dachaigh › Gnìomhan › Natural Sciences Managers › South San Francisco, CA
Natural Sciences Managers ann an South San Francisco, CA: Tuarastalan H-1B
37 iarrtasan cumhaichean-obrach airson an dreuchd seo le làrach-obrach ann an South San Francisco, CA. Tuarastal bunasach meadhanach $193,170; leth meadhanach $161,508–$223,034.
A rèir ìre tuarastail
| Ìre tuarastail | Tuarastal meadhanach |
|---|---|
| Ìre I (innte) | $170,000 |
| Ìre II (càileachail) | $193,170 |
| Ìre III (eòlach) | $249,105 |
| Ìre IV (gu lèir comasach) | $258,669 |
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Luchd-fastaidh
| Neach-obrach | LCAs | Tuarastal meadhanach |
|---|---|---|
| Genentech, Inc. | 8 | $197,010 |
| Denali Therapeutics Inc. | 4 | $225,017 |
| Ideaya Biosciences Inc. | 3 | $161,508 |
| Sutro Biopharma, Inc. | 3 | $205,500 |
| GlaxoSmithKline LLC | 1 | $183,532 |
| Twist Bioscience Corporation | 1 | $140,000 |
| Vaxart, Inc. | 1 | $151,372 |
| Freenome Holdings, Inc. | 1 | $220,000 |
| Blue Matter Consulting LLC | 1 | $170,000 |
| Nkarta, Inc. | 1 | $127,239 |
| CytomX Therapeutics, Inc. | 1 | $193,170 |
| Aligos Therapeutics, Inc. | 1 | $230,000 |
| California Institute for Regenerative Medicine | 1 | $123,600 |
| Neurona Therapeutics, Inc. | 1 | $107,434 |
| Agrim Technologies Inc | 1 | $135,200 |
| TheRas Inc. | 1 | $185,000 |
| Calico Life Sciences LLC | 1 | $225,000 |
| Assembly Biosciences, Inc. | 1 | $233,210 |
| Spruce Biosciences, Inc. | 1 | $266,000 |
| Abbvie Biotherapeutics Inc. | 1 | $209,000 |
| Horizon Therapeutics USA, Inc. | 1 | $294,755 |
| Amgen Inc. | 1 | $190,000 |
| Mission Bio, Inc. | 1 | $170,000 |
Tiotalan dreuchd
- Clinical Trial Manager3
- Director, Clinical Operations2
- Senior Pharmacovigilance Clinical Manager2
- Associate Director, Statistical Programming2
- Associate Director of Upstream Process Development1
- Director, AI/ML Engineering1
- Technical Program Manager, Bioinformatics1
- Materials Manager1
- Senior Program Manager1
- Clinical Research Coordinator1
- Senior Director1
- Senior Fellow1
- Manager - Life Sciences Strategy1
- Program Director1
- Manager - Clinical Trials1
Luchd-taic H-1B ann an South San Francisco, CA →
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).